A competitor's device just got recalled. Your auditor will ask: 'How did you evaluate whether this affects your products?' You're reviewing the alert, knowing it could trigger a supplier audit or requ

Here's what's happening right now: 2 new Health Canada recalls were issued this week, both for product safety issues. Auro-Canagliflozin has affected lots with incorrect DIN labeling on blister cards, and LUXA-D has a capsule containing a foreign product in the batch. This adds to 10,360 new FDA Adverse Event Reports (MAUDE/MDRs) and 22 new Health Canada mdl signals today, totaling 10,384 new regulatory signals.

For RA Managers focused on audit preparedness and post-market surveillance, these signals highlight critical gaps in labeling controls and foreign material contamination—common triggers for MDSAP audits and QMSR compliance reviews. The pattern suggests a need to proactively assess your supply chain and labeling processes, as similar issues could impact your submissions or lead to 21 CFR 820 non-conformances if not addressed in your QMS.

We analyzed this across 548,000+ regulatory records and found that labeling errors and contamination events often cluster in specific product categories, requiring targeted monitoring to mitigate risk.

See how these signals map to your product portfolio with our free tool at truemeddevice.com.